Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
DNA and Cell Biology
|
February 15, 2001
Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes
M Henson, D Damm, A Lam, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
March 1, 1975
[Study of interventricular septal defects with equal aortic and pulmonary artery pressures. Classification by clinical and computer methods of 70 cases]
J Valty, G Leduc, E Ruiz, et al.
Nature Communications
|
March 28, 2019
Author Correction: Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
A Flores, S Sandoval-Gonzalez, R Takahashi, et al.
Nature Communications
|
January 11, 2019
Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
A Flores, S Sandoval-Gonzalez, R Takahashi, et al.
Journal of Neurovirology
|
November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication
Matteo Vassallo, R Fabre, J Durant, et al.
Journal of the American Society of Nephrology : JASN
|
June 26, 2001
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1
Duk-Hee Kang, Alison H Joly, Se-Woong Oh, et al.
Nature Communications
|
January 21, 2021
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Joseph C Reynolds, Rochelle W Lai, Jonathan S T Woodhead, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 28, 2013
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer
Frauke Bentzien, Marcus Zuzow, Nathan Heald, et al.
Cancer Research
|
October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Molecular Cancer Therapeutics
|
September 20, 2011
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
F Michael Yakes, Jason Chen, Jenny Tan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
DNA and Cell Biology
|
February 15, 2001
Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes
M Henson, D Damm, A Lam, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
March 1, 1975
[Study of interventricular septal defects with equal aortic and pulmonary artery pressures. Classification by clinical and computer methods of 70 cases]
J Valty, G Leduc, E Ruiz, et al.
Nature Communications
|
March 28, 2019
Author Correction: Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
A Flores, S Sandoval-Gonzalez, R Takahashi, et al.
Nature Communications
|
January 11, 2019
Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
A Flores, S Sandoval-Gonzalez, R Takahashi, et al.
Journal of Neurovirology
|
November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication
Matteo Vassallo, R Fabre, J Durant, et al.
Journal of the American Society of Nephrology : JASN
|
June 26, 2001
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1
Duk-Hee Kang, Alison H Joly, Se-Woong Oh, et al.
Nature Communications
|
January 21, 2021
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Joseph C Reynolds, Rochelle W Lai, Jonathan S T Woodhead, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 28, 2013
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer
Frauke Bentzien, Marcus Zuzow, Nathan Heald, et al.
Cancer Research
|
October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Molecular Cancer Therapeutics
|
September 20, 2011
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
F Michael Yakes, Jason Chen, Jenny Tan, et al.
Page
of 7